Cargando…
Simvastatin Blocks Blood-Brain Barrier Disruptions Induced by Elevated Cholesterol Both In Vivo and In Vitro
Background. Hypercholesterolemia and disruptions of the blood brain barrier (BBB) have been implicated as underlying mechanisms in the pathogenesis of Alzheimer's disease (AD). Simvastatin therapy may be of benefit in treating AD; however, its mechanism has not been yet fully understood. Object...
Autores principales: | Jiang, Xijuan, Guo, Maojuan, Su, Jinling, Lu, Bin, Ma, Dongming, Zhang, Ruifeng, Yang, Lin, Wang, Qiang, Ma, Yiwen, Fan, Yingchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296225/ https://www.ncbi.nlm.nih.gov/pubmed/22506129 http://dx.doi.org/10.1155/2012/109324 |
Ejemplares similares
-
A Cocktail Method for Promoting Cardiomyocyte Differentiation from Bone Marrow-Derived Mesenchymal Stem Cells
por: Gao, Qing, et al.
Publicado: (2014) -
Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo
por: Hong, Yun, et al.
Publicado: (2022) -
Investigation of the Inhibitory Effect of Simvastatin on the Metabolism of Lidocaine Both in vitro and in vivo
por: Wang, Ying, et al.
Publicado: (2020) -
Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2010) -
Ezetimibe and Simvastatin Reduce Cholesterol Levels in Zebrafish Larvae Fed a High-Cholesterol Diet
por: Baek, Ji Sun, et al.
Publicado: (2012)